Anthrax vaccination strategies-Reference-Cited by-同舟云学术

Anthrax vaccination strategies

Published:2009-12 Issue:6 Volume:30 Page:490-502
ISSN:0098-2997
Container-title:Molecular Aspects of Medicine
language:en
Short-container-title:Molecular Aspects of Medicine

Author:

Cybulski Robert J.,Sanz Patrick,O’Brien Alison D.

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Molecular Biology,Molecular Medicine,General Medicine,Biochemistry

Reference184 articles.

1. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax;Albrecht;Infect. Immun.,2007

2. Oral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigen;Aloni-Grinstein;Infect. Immun.,2005

3. Anthrax toxin: a tripartite lethal combination;Ascenzi;FEBS Lett.,2002

4. Studies on immunity in anthrax. VI. Immunizing activity of protective antigen against various strains of Bacillus anthracis;Auerbach;J. Immunol.,1955

5. Combining anthrax vaccine and therapy: a dominant-negative inhibitor of anthrax toxin is also a potent and safe immunogen for vaccines;Aulinger;Infect. Immun.,2005

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bacillus anthracis infection in humans and animals;Medycyna Weterynaryjna;2024

2. Bacterial skin infections I. - infections caused by gram-positive bacteria;Dermatologie pro praxi;2023-11-21

3. Protective antigen of Bacillus anthracis in combination with TLR4 or TLR5 agonist confers superior protection against lethal challenge in mouse model;Microbes and Infection;2023-11

4. Immunogenicity and Protective Efficacy of Recombinant Protective Antigen Anthrax Vaccine (GC1109) in A/J Mice Model;Vaccine;2023-05

5. Recent Trends in Protective Textiles against Biological Threats: A Focus on Biological Warfare Agents;Polymers;2022-04-14